Community
TrustFinance is trustworthy and accurate information you can rely on. If you are looking for financial business information, this is the place for you. All-in-One source for financial business information. Our priority is our reliability.

TrustFinance Global Insights
3月 23, 2026
2 min read
69

Shares of Croda International, a U.K.-based specialty chemicals company, surged more than 2 percent following a significant double upgrade from Goldman Sachs. The investment bank raised its recommendation on the stock to “Buy” from a previous “Sell” rating.
Goldman Sachs also increased its 12-month price target for Croda to 3,200 pence from 2,800 pence. This revised target suggests a potential upside of 25.3 percent from the stock's closing price of 2,554 pence last Friday. The upgrade marks a notable reversal in sentiment, coming nearly a year after the firm had placed Croda on its sell list.
The positive reassessment from a major financial institution like Goldman Sachs immediately boosted investor confidence. The resulting share price increase reflects the market's reaction to the improved growth prospects and higher valuation target for the specialty chemicals maker.
This double upgrade is a key positive catalyst for Croda International's stock. Investors will now closely monitor the company's performance to see if it aligns with Goldman Sachs' optimistic forecast. The focus will be on whether the anticipated growth materializes and justifies the new 'Buy' rating and price target.
Q: What is a double upgrade?
A: A double upgrade occurs when an analyst raises a stock's rating by two levels at once, for example, from 'Sell' directly to 'Buy', skipping the intermediate 'Hold' or 'Neutral' rating.
Q: What was the new price target for Croda stock?
A: Goldman Sachs set a new 12-month price target of 3,200 pence for Croda International.
Source: Investing.com

TrustFinance Global Insights
AI-assisted editorial team by TrustFinance curating reliable financial and economic news from verified global sources.
Related Articles